148 related articles for article (PubMed ID: 28421700)
1. Growth characteristics and endocrine abnormalities in 22q11.2 deletion syndrome.
Levy-Shraga Y; Gothelf D; Goichberg Z; Katz U; Somech R; Pinhas-Hamiel O; Modan-Moses D
Am J Med Genet A; 2017 May; 173(5):1301-1308. PubMed ID: 28421700
[TBL] [Abstract][Full Text] [Related]
2. Endocrine and Growth Disorders in Taiwanese Children With 22q11.2 Deletion Syndrome.
Lin HY; Tsai WY; Tung YC; Liu SY; Lee NC; Chien YH; Hwu WL; Lee CT
Front Endocrinol (Lausanne); 2022; 13():771100. PubMed ID: 35432203
[TBL] [Abstract][Full Text] [Related]
3. Endocrine manifestations of chromosome 22q11.2 microdeletion syndrome.
Choi JH; Shin YL; Kim GH; Seo EJ; Kim Y; Park IS; Yoo HW
Horm Res; 2005; 63(6):294-9. PubMed ID: 15995343
[TBL] [Abstract][Full Text] [Related]
4. Endocrine Abnormalities and Growth Characterization in Colombian Pediatric Patients with 22q11 Deletion Syndrome.
Lasprilla-Tovar J; Zuluaga NA; Forero C; Correa-Jiménez O; Sierra JM
J Clin Res Pediatr Endocrinol; 2023 Feb; 15(1):16-24. PubMed ID: 35984227
[TBL] [Abstract][Full Text] [Related]
5. [22q11.2 deletion syndrome diagnosed in an adult male].
Hassing RJ; Verhagen JM; van de Laar IM; van Daele PL
Ned Tijdschr Geneeskd; 2011; 155(40):A3644. PubMed ID: 21988757
[TBL] [Abstract][Full Text] [Related]
6. A patient with 22q11.2 deletion syndrome: case report.
Eryılmaz SK; Baş F; Satan A; Darendeliler F; Bundak R; Günöz H; Saka N
J Clin Res Pediatr Endocrinol; 2009; 1(3):151-4. PubMed ID: 21274400
[TBL] [Abstract][Full Text] [Related]
7. Transient congenital hypoparathyroidism: resolution and recurrence in chromosome 22q11 deletion.
Greig F; Paul E; DiMartino-Nardi J; Saenger P
J Pediatr; 1996 Apr; 128(4):563-7. PubMed ID: 8618195
[TBL] [Abstract][Full Text] [Related]
8. Endocrine manifestations in children with Williams-Beuren syndrome.
Levy-Shraga Y; Gothelf D; Pinchevski-Kadir S; Katz U; Modan-Moses D
Acta Paediatr; 2018 Apr; 107(4):678-684. PubMed ID: 29266477
[TBL] [Abstract][Full Text] [Related]
9. Hypoparathyroidism and autoimmunity in the 22q11.2 deletion syndrome.
Lima K; Abrahamsen TG; Wolff AB; Husebye E; Alimohammadi M; Kämpe O; Følling I
Eur J Endocrinol; 2011 Aug; 165(2):345-52. PubMed ID: 21606191
[TBL] [Abstract][Full Text] [Related]
10. Head and neck manifestations of 22q11.2 deletion syndromes.
Marom T; Roth Y; Goldfarb A; Cinamon U
Eur Arch Otorhinolaryngol; 2012 Feb; 269(2):381-7. PubMed ID: 21861138
[TBL] [Abstract][Full Text] [Related]
11. Delayed-onset hypoparathyroidism in an adolescent with chromosome 22Q11 deletion syndrome.
Kambo JS; Girgis CM; Champion BL; Wall JR
Endocr Pract; 2011; 17(5):e123-5. PubMed ID: 21803718
[TBL] [Abstract][Full Text] [Related]
12. Auxological evaluation in patients with a 22q11.2 microdeletion syndrome: normal prevalence of obesity and neonatal length and gender influence on body mass index evolution.
Reynaud R; Derain-Court J; Braunstein D; Veyrat M; Gaudart J; Giuliano F; Philip N
Horm Res Paediatr; 2011; 76(3):172-7. PubMed ID: 21829000
[TBL] [Abstract][Full Text] [Related]
13. Association of airway abnormalities with 22q11.2 deletion syndrome.
Sacca R; Zur KB; Crowley TB; Zackai EH; Valverde KD; McDonald-McGinn DM
Int J Pediatr Otorhinolaryngol; 2017 May; 96():11-14. PubMed ID: 28390597
[TBL] [Abstract][Full Text] [Related]
14. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
[TBL] [Abstract][Full Text] [Related]
15. CATCH 22: deletion of locus 22q11 in velocardiofacial syndrome, DiGeorge anomaly, and nonsyndromic conotruncal defects.
Hou JW; Wang JK; Tsai WY; Chou CC; Wang TR
J Formos Med Assoc; 1997 Jun; 96(6):419-23. PubMed ID: 9216164
[TBL] [Abstract][Full Text] [Related]
16. Hypoparathyroidism and 22q11 deletion syndrome.
Taylor SC; Morris G; Wilson D; Davies SJ; Gregory JW
Arch Dis Child; 2003 Jun; 88(6):520-2. PubMed ID: 12765920
[TBL] [Abstract][Full Text] [Related]
17. An Endocrinological Perspective on 22q11.2 Deletion Syndrome: A Single-center Experience.
Denkboy Öngen Y; Özemri Sağ Ş; Temel ŞG; Eren E
J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):285-292. PubMed ID: 37074225
[TBL] [Abstract][Full Text] [Related]
18. Schizophrenia-like neurophysiological abnormalities in 22q11.2 deletion syndrome and their association to COMT and PRODH genotypes.
Zarchi O; Carmel M; Avni C; Attias J; Frisch A; Michaelovsky E; Patya M; Green T; Weinberger R; Weizman A; Gothelf D
J Psychiatr Res; 2013 Nov; 47(11):1623-9. PubMed ID: 23910792
[TBL] [Abstract][Full Text] [Related]
19. [Graves disease and IgA deficiency as manifestations of 22q11.2 deletion syndrome].
Silva JM; Silva CP; Melo FF; Silva LA; Utagawa CY
Arq Bras Endocrinol Metabol; 2010 Aug; 54(6):572-7. PubMed ID: 20857064
[TBL] [Abstract][Full Text] [Related]
20. What is new with 22q? An update from the 22q and You Center at the Children's Hospital of Philadelphia.
Campbell IM; Sheppard SE; Crowley TB; McGinn DE; Bailey A; McGinn MJ; Unolt M; Homans JF; Chen EY; Salmons HI; Gaynor JW; Goldmuntz E; Jackson OA; Katz LE; Mascarenhas MR; Deeney VFX; Castelein RM; Zur KB; Elden L; Kallish S; Kolon TF; Hopkins SE; Chadehumbe MA; Lambert MP; Forbes BJ; Moldenhauer JS; Schindewolf EM; Solot CB; Moss EM; Gur RE; Sullivan KE; Emanuel BS; Zackai EH; McDonald-McGinn DM
Am J Med Genet A; 2018 Oct; 176(10):2058-2069. PubMed ID: 30380191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
